Title:Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD
Volume: 18
Issue: 9
关键词:
阿尔茨海默病,tau蛋白病理,微血管灌注,多模态神经成像,正电子发射断层摄影术,动态磁化率对比磁共振成像,脑血管功能
摘要:
Background: Reduced cerebrovascular function and accumulation of tau pathology are
key components of cognitive decline in Alzheimer’s disease (AD). Recent multimodal neuroimaging
studies show a correlation between cortical tau accumulation and reduced cerebral perfusion.
However, animal models predict that tau exerts capillary-level changes that may not be fully captured
by standard imaging protocols.
Objective: Using newly-developed magnetic resonance imaging (MRI) technology to measure capillary-
specific perfusion parameters, we examined a series of mild cognitive impairment (MCI) and
AD patients with tau positron emission tomography (PET) to observe whole-brain capillary perfusion
alterations and their association with tau deposition.
Methods: Seven subjects with MCI or AD received Flortaucipir PET to measure tau deposition
and spin-echo dynamic susceptibility contrast (SE-DSC) MRI to measure microvascular perfusion
(<10μm radius vessels). Gradient-echo (GE) DSC and pseudocontinuous arterial spin labeling (PCASL)
MRI were also acquired to assess macrovascular perfusion. Tau PET, microvascular perfusion,
and cortical thickness maps were visually inspected in volumetric slices and on cortical surface
projections.
Results: High tau PET signal was generally observed in the lateral temporal and parietal cortices,
with uptake in the occipital cortex in one subject. Global blood flow measured by PCASL was reduced
with increasing tau burden, which was consistent with previous studies. Tau accumulation
was spatially associated with variable patterns of microvascular cerebral blood flow (CBF) and oxygen
extraction fraction (OEF) in the cortex and with increased capillary transit heterogeneity (CTH)
in adjacent periventricular white matter, independent of amyloid-β status.
Conclusion: Although macrovascular perfusion generally correlated with tau deposition at the
whole-cortex level, regional changes in microvascular perfusion were not uniformly associated
with either tau pathology or cortical atrophy. This work highlights the heterogeneity of AD-related
brain changes and the challenges of implementing therapeutic interventions to improve cerebrovascular
function.